↓ Skip to main content

Exquisite Sensitivity to Dual BRG1/BRM ATPase Inhibitors Reveals Broad SWI/SNF Dependencies in Acute Myeloid Leukemia

Overview of attention for article published in Molecular Cancer Research, March 2022
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (65th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (61st percentile)

Mentioned by

twitter
6 tweeters

Citations

dimensions_citation
1 Dimensions

Readers on

mendeley
12 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Exquisite Sensitivity to Dual BRG1/BRM ATPase Inhibitors Reveals Broad SWI/SNF Dependencies in Acute Myeloid Leukemia
Published in
Molecular Cancer Research, March 2022
DOI 10.1158/1541-7786.mcr-21-0390
Pubmed ID
Authors

Florencia Rago, Lindsey Ulkus Rodrigues, Megan Bonney, Kathleen Sprouffske, Esther Kurth, GiNell Elliott, Jessi Ambrose, Peter Aspesi, Justin Oborski, Julie T. Chen, E. Robert McDonald, Felipa A. Mapa, David A. Ruddy, Audrey Kauffmann, Tinya Abrams, Hyo-eun C. Bhang, Zainab Jagani

Twitter Demographics

The data shown below were collected from the profiles of 6 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 12 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 12 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 3 25%
Student > Ph. D. Student 2 17%
Student > Postgraduate 2 17%
Student > Master 2 17%
Student > Bachelor 1 8%
Other 0 0%
Unknown 2 17%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 5 42%
Agricultural and Biological Sciences 3 25%
Social Sciences 1 8%
Unknown 3 25%

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 May 2022.
All research outputs
#6,465,897
of 21,385,220 outputs
Outputs from Molecular Cancer Research
#522
of 1,797 outputs
Outputs of similar age
#162,321
of 469,489 outputs
Outputs of similar age from Molecular Cancer Research
#14
of 34 outputs
Altmetric has tracked 21,385,220 research outputs across all sources so far. This one has received more attention than most of these and is in the 69th percentile.
So far Altmetric has tracked 1,797 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.9. This one has gotten more attention than average, scoring higher than 69% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 469,489 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 65% of its contemporaries.
We're also able to compare this research output to 34 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 61% of its contemporaries.